AND017
In normoxia, the enzyme called prolyl hydroxylase (PH) can hydroxylate hypoxiainducible-factor (HIF)
MORE
| Program | Indication | Discovery | IND Approval | Phase I | Phase II | |
|
AND017 (HIF-PHI) |
Anemia |
Phase II FDA IND Approval on Jan 14 2021 |
||||
|
AND017 (HIF-PHI) |
Cancer Related Anemia |
Phase II NMPA Approval on May 23 2022 |
||||
|
AND019（SERD） |
Breast Cancer |
Phase I FDA IND Approval on Oct 1 2021 |
||||
|
ADC |
Cancers |
Pre-Clinical |
||||
|
AND021 |
Renal Cell Carcinoma |
Pre- Clinical |
||||
Our products
